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The objectives of this study were to determine the prevalence of asthma, atopy and COPD in
Rwanda and to identify risk factors. The survey was conducted in Kigali, the Capital of Rwanda,
and in Huye District, a rural area located in southern Rwanda.
Methods: A total of 2138 subjects were invited to participate in the study.1920 individuals
(90%) answered to questionnaires on respiratory symptoms and performed spirometry, 1824
had acceptable spirograms and performed skin-prick test. In case of airflow obstruction
(defined as pre-bronchodilator ratio FEV1/FVC < LLN) a post bronchodilator spirometry was
performed. Reversibility was defined as an increase in FEV1 of 200 ml and 12% above baseline
FEV1 after inhalation of 400 mcg of salbutamol.
Results: The mean age was 38.3 years; 48.1% of participants were males and 51.9% females.
Airflow obstruction was found in 256 participants (14%); 163(8.9%) subjects were asthmatics
and 82 (4.5%) had COPD. COPD was found in 9.6% of participants aged 45 years and above.
484 subjects had positive skin-prick tests (26.5%); house dust mite and grass pollen mix were
the main allergens. Risk factors for asthma were allergy, female gender and living in Kigali.
COPD was associated with cigarette smoking, age and male sex.
Conclusion: this is the first study which shows the prevalence of atopy, asthma and COPD in
Rwanda. Asthma and COPD were respectively diagnosed in 8.9% and 4.5% of participants. COPD
was diagnosed in 9.6% of subjects aged 45 years.The prevalence of asthma was higher in
urban compared to rural area.
ª 2011 Elsevier Ltd. All rights reserved.iversity of Rwanda, Faculty of Medicine, University Avenue, PO box 117, Butare, Rwanda. Tel.: þ250
(S. Musafiri).
1 Elsevier Ltd. All rights reserved.
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Chronic obstructive pulmonary disease (COPD) and asthma
are major health problems worldwide and the number of
patients with these diseases continues to rise.1 It is pre-
dicted that by the year 2020, COPD will be the third leading
cause of death and the fifth leading cause of disability
adjusted life years worldwide.2
Most of available information of the disease burden of
chronic lung diseases comes from industrialized countries.
One of the more troubling aspects of COPD is that it is
under-recognized by the patient, under diagnosed by the
physicians, and arguably undertreated. This may cause an
important role in the increase in mortality and morbidity as
a result of asthma or COPD.3 Tobacco smoking is by far the
major risk factor for COPD and the prevalence of the
disease in different countries is related to rate of smoking
and time of introduction of cigarette smoking.4 The use of
biomass fuel has also been associated with the occurrence
of obstructive airways disorders.5
In Africa, COPD rate is rising because of an increase of
tobacco consumption. The prevalence of tobacco use in
African countries is between 8 and 43% for men and 5e30%
for women and there are intensive efforts by the Tobacco
industry to expand African markets.6 If nothing is done to
stop this rate of growth, Africa will have one of the world
highest levels of tobacco consumption.7 In Rwanda, COPD is
not known in general population; it is even sometimes
ignored by some health care workers including medical
doctors.
The prevalence of asthma throughout Africa has
increased markedly in recent years, having previously been
uncommon over most parts of the continent. Prevalence
data are lacking for many countries in Africa including
Rwanda, but it is estimated that nearly 50 millions of
Africans currently have asthma. The prevalence of the
disease is greatest, about 8% of the population in Southern
Africa.8 A clinical overlap between asthma and COPD often
occur in patients who smoke.4 Efforts to improve care of
patients with asthma and allergic conditions is in some
developing countries being overwhelmed by the burden of
tuberculosis, HIV/AIDS and other infectious diseases.9
The overall objective of this cross-sectional observa-
tional study was to determine the prevalence of atopy,
asthma and COPD in Huye District and Kigali town, to
determine the risk factors and compare the city of Kigali
(urban) and the District of Huye (rural)
Patients and methods
Between February 2008 and August 2009, a total of 2138
individuals have been randomly recruited in the rural
district of Huye and in Kigali town localized respectively at
1568 m and 1768 m of altitude. In Kigali, the study was
performed in Nyarugenge district considered as the gate of
the country, based around the city centre of Kigali, more
polluted and containing most of the city’s businesses with
an urban population of 193000 subjects.10 Nyarugenge is
known to be representative of the larger population of
Kigali in terms of housing, socio economic status and air
quality. Huye district is localized in southern Rwanda andwas chosen because it is less polluted and it is the only rural
district in the country that has a University Hospital where
spirometers could be regularly maintained. The district has
a population of 290000 subjects but recruitment was done
among 150000 individuals living in the rural side of the
district.11
Nyarugenge district is divided into 10 administrative
sectors and Huye district has 14 administrative sectors.
Each sector has a population register regularly updated.
Using population registers systematic sampling was used to
obtain probabilistic samples that are representative of the
total population. The sample size was estimated at 2138
subjects aged 15e80 years (1184 in Kigali and 954 in Huye
district). Participants were invited in Health centers where
a structured interview was conducted by well trained
health workers. Three health centers were available in
Kigali and three others in Huye district.
Inclusion criteria were age  15 years, living in Kigali
town or Huye District and being competent and willing to
sign the informed consent form after being given all the
details about the study.
Exclusion criteria for the study were age below 15 years
or having any mental illness, recent myocardial infarction
or history of admission for cardiac illness within the last 5
months, recent thoracic, abdominal or eye surgery (or
retinal detachment) and pregnant women. Subjects with
active tuberculosis or any acute lung infections were also
excluded. Only those who signed the informed consent
form participated in the study.
After height and weight were measured, a questionnaire
on respiratory symptoms and history of respiratory
diseases, smoking history, exposure to various chemical
agents and dust was administrated to each participant. A
stadiometer with a precision of 0.1 cm was used for
measuring height while the subject standing without shoes.
A weighing scale with a precision of 100 g was used for
measuring weight. Body mass index was calculated as
weight (in kilograms) divided by height (in meters) squared.
For smoking history, non-smokers were defined as those
who never had smoked; smokers were those who were
currently smoking at least one cigarette per day, and ex-
smokers those who reported having smoked on a regular
basis until  5 months before the examination. Passive
smokers were defined as subjects who were regularly (daily
basis) exposed to environmental tobacco smoke at least
during the last 12 months. The questionnaires used were
a short version of the American Thoracic Society12 and the
European Community Respiratory Health Survey II
questionnaires.13
Spirometry was performed using an ML 3535 microloop
spirometer with a database storage capacity for over 1000
patients (Microloop 3535, SPIDA spirometry, Micromedical
limited, UK). The spirometric parameters used were: FEV1
(Forced Expiratory Volume in 1 s), FVC (Forced Vital
Capacity), FEV1/FVC ratio and PEF (Peak Expiratory
Flow).
After explanation of the procedures and demonstration
by the technician, using local language, participants were
asked to perform up to 8 maneuvers to obtain 3 acceptable
flow-volume curves. The spirometry with largest value of
FVC and FEV was considered as the best and used for
analysis. Equipments and procedures were in accordance
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Spirometers were daily calibrated using a 3 L’s syringe.
The Global Initiative of Chronic Lung Disease (GOLD)
guidelines define COPD in subjects with FEV1/FVC of less
than 70%.2 Many authors showed that this fixed cut-off of
0.70 can lead to an overestimation of COPD prevalence in
elderly subjects. Moreover as asthma is a disease of
predominantly young people, the GOLD criterion may fail to
diagnose many asthmatics as having obstruction.15,16
In this study, we used the ATS/ERS guidelines17 on lung
function testing proposing use of the lower limit of
normality (LLN) instead of a fixed cut-off of 0.70. The lower
limit of normal is the fifth percentile which is equivalent to
1.645 SD below predicted.17
The reference equations for LLN defined by the ratio
FEV1/FVC were:
eðFEV1=FVC predictedÞð1:6450:06Þ for males

eX : ExpðXÞ
eðFEV1=FVC predictedÞð1:6450:08Þ for females
where FEV1/FVC predicted Z Exp (7.1477e0.518 ln(H) e
0.001025A) for males and Exp (5.848 þ 0.268 ln(H) e
0.000839 A) for females, age is expressed in years.(A: age,
H: height, ln: natural logarithm)
Based on the reference equations generated from
healthy non smoking subjects in this study, the lower limits
of the normal were calculated for each subject and the
presence of airflow limitation was defined as FEV1/FVC less
than the LLN.
Healthy subjects for generating reference values were
defined as those who did not smoke or report respiratory
symptoms (cough, phlegm, dyspnea or wheezing); those
who had no medical diagnosis of COPD, asthma, chronic
bronchitis, emphysema, lung fibrosis and had no history of
pulmonary tuberculosis, lung cancer or lung resection.
For subjects with airways obstruction as defined above,
a short acting b2 agonist was administered by inhalation
(salbutamol 400 mg) through a 500 ml spacer, to check the
reversibility of the obstruction, and spirometry was
repeated 15 min later with the same criteria. Reversibility
was considered as significant if there was an FEV1 increase
of 200 ml and 12% above baseline FEV1.
17 For the LLN, the
cut-of value of the post-bronchodilator ratio was set at the
fifth percentile of the normal distribution.
Asthma versus COPD
Asthma and COPD are two different respiratory chronic
diseases characterized both by airflow limitation. Airflow
limitation in asthma is by definition reversible either
spontaneously or as a result of treatment, whereas in COPD
airflow limitation is not fully reversible and is progressive.18
Diagnosis of asthma
Clinical diagnosis of asthma is difficult and many epidemi-
ological studies have used symptom questionnaires to
distinguish asthmatics and non asthmatics subjects. Diag-
nosis of asthma made by a health care provider still remainsthe most common approach used to define asthma in
epidemiological studies.19
In our study, after excluding any cardiac disease, 2
conditions were taken into account for the diagnosis of
asthma:
1. All participants whose diagnosis of asthma was
confirmed by a medical doctor and who reported one of
the following symptoms during the last 12 months12,13:
- Episodic wheezes
- episodic wheezes and attacks of shortness of breath
- Nocturnal attacks of shortness of breath
- Use of asthma medication
2. Subjects who presented with reversible airways
obstruction as defined above at the time of recruitment
in the study (pre-bronchodilator FEV1/FVC < LLN and
a positive reversibility test meaning an increase in FEV1
of 200 ml and 12% with respect to pre-bronchodilator
FEV1 after 400 mcg of salbutamol)
Diagnosis of COPD
In this study, chronic obstructive pulmonary disease (COPD)
was defined as post bronchodilator FEV1/FVC less than the
LLN. Subjects with a doctor diagnosis of COPD were those
who reported a physician’s diagnosis of chronic bronchitis,
emphysema or COPD.
Skin-prick testing
All the patients were skin-prick tested for six common
allergen extracts (Laboratoire Stallerge`ne, Waterloo,
Belgium): house dust mite, grass pollen mix, cat dander,
dog dander, aspergillus and cockroach plus a negative and
positive control (Histamine). After cleaning the forearm of
the participant, a drop of each allergen extract was placed
on the anterior side of the forearm with an interval of 2 cm
between 2 drops. A sterile lancet (stallerpoint) was used to
prick the centre of the drop. Results were read 15 min later
and sensitization was defined as wheal at least 3 mm
greater than the negative control.
Ethical considerations
Ethical approval was obtained from both the Ghent
University Hospital Ethics Committee (Belgium) and the
Rwanda National Ethics Committee. Only subjects who
signed the informed consent form participated in the
study.
Statistical methods
Statistical analyses were performed using the statistical
package SPSS 12.01 and statistical significance was viewed
as P values lower than 0.05. Odds ratios (OR) and 95%
confidence intervals (CI) were calculated, the data of
height, age and lung function parameters were expressed
as means  SD (Standard deviation). Ratio FEV1/FVC was
expressed as a percentage. A logistic regression model was
performed using age, gender, smoking, residential area as
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dependant variables.Results
Of the 2138 subjects initially invited, 48 (2.2%) refused to
participate and 170 (7.9%) were excluded because they did
not meet the inclusion criteria (26% were under tubercu-
losis treatment, 18% were pregnant, 15% were in heart
failure, 7% had mental diseases, 34% had a recent abdom-
inal/thoracic/eye surgical history). A total of 1920 indi-
viduals aged 15e80 years responded to questionnaires and
underwent spirometry. Subjects performed at least three
spirometry measurements acceptable by the ATS criteria.
96 individuals were excluded from the analysis due to the
inability to perform acceptable spirograms. We remained
with 1824 subjects composed of 946 women and 878 men,
mean age was 38.3 years. (Fig. 1)
65.2% of participants were below age 45 years and 34.8%
above 45 years; this reflects the Rwandan general pop-
ulation distribution where more than 60% of the population
is under 40 years and where women are overrepresented
(88 males for every 100 females in the general pop-
ulation).20 67.8% of subjects had a normal BMI, 17.1% were
overweighted and 5.9% had obesity. 26.7% have never been
at school. The characteristics of participants are shown in
Table 1Figure 1 Flow diagram of the study population.Prevalence of smokers
56.8% of subjects were living in Kigali and 43.2% in Huye
district. More than the half of participants had never-
smoked cigarettes, 15.8% were ex-smokers (19.8% of men
and 11.8% of women) and 16.7% were current smokers
(20.9% of men and 12.6% of women). Passive smoking was
found in 542 patients (29.7%). 26.5% participants reported
an exposure to smoke from wood stoves and 28.2% were
exposed to smoke from charcoal stoves. Occupational
exposure to dust was reported by 20.5% of participants. The
prevalence of current smokers was significantly higher in
men than in women (p < 0.05). (Table 2)Respiratory symptoms
228 (12.5%) participants reported episodes of wheezes,
among them 24 (10.5%) had a history of tuberculosis. Cough
with phlegm was reported by 96 participants. 121 (6.6%)
subjects reported a doctor’s diagnosis of asthma (Table 3).Spirometry
Of the 1824 subjects who performed spirometry, 256 (14%)
were classified as having airflow obstruction with a ratio
FEV1/FVC < LLN. All participants with airflow limitation
underwent a post bronchodilator spirometry, among them,
174 out of 256 subjects (94 females and 80 males) had
a significant improvement of FEV1 which was greater or
equal to 12% predicted and 200 ml.
Asthma was diagnosed in 163 (8.9%) individuals (Table
4). 11 subjects who had a good reversibility after adminis-
tration of a bronchodilator were not considered as asth-
matics since they reported a history of tuberculosis and
mentioned that asthma-like symptoms started after
tuberculosis treatment. With regard to doctor’s diagnosis of
asthma, 121 (74.2%) out of 163 individuals who met our
criteria for asthma had a doctor’s diagnosis of asthma.
COPD was diagnosed in 82 (4.5%) subjects who presented
a ratio FEV1/FVC less than the LLN and was more frequently
diagnosed in men than in women the difference was statis-
tically significant. The prevalence of COPD was higher among
current (11.2%) and ex-smokers (8.6%) compared to non-
smokers (1.9%). 59 (71.9%) subjects with COPD were current
smokers or ex-smokers and about one third (28%) were non-
smokers. Among 635 individuals aged 45 years and above,
COPD was diagnoses in 9.6% of subjects. With regard to
doctor’s diagnosis of COPD, only 5 (6.1%) out of 82 individuals
who met our criteria for COPD had a doctor’s diagnosis of
COPD. Spirometry baseline information is given in Table 5.
FEV1, FVC and ratio FEV1/FVC were lower in current
smokers and ex-smokers over 45 years than in never-
smoked subjects. Airflow obstruction was classified as
mild, moderate, severe and very severe according to the
GOLD classification21; we had only 4 COPD patients with
severe obstruction. Although the use of LLN criterion was
preferred in this study an effort was made to compute
prevalence rates of the airflow limitation by the Gold
criteria (Fixed ratio: FEV1/FVC < 0.70) for comparison.
Using this criterion, a total of 212 (11.6%) subjects were
Table 1 Description of the sample according to socio-demographic variables and anthropometric measures.
Variables Kigali Huye N
Gender
Men 502 376 878 (48.1%)
Women 534 412 946 (51.9%)
Age (years)
15e29 396 308 704 (38.6%)
Male 200 158 358 (40.7%)
Female 196 150 346 (36.5%)
30e44 286 199 485 (26.6%)
Male 134 96 230 (26.2%)
Female 152 103 255 (27.0%)
45e60 249 212 461 (25.3%)
Male 120 96 216 (24.6%)
Female 129 116 245 (25.9%)
>60 105 69 174 (9.6%)
Male 41 33 74 (8.5%)
Female 66 34 100 (10.6%)
Marital status
Never married 420 378 798 (43.8%)
Married 348 336 684 (37.5%)
Divorced/separated 46 50 96 (5.3%)
Widowed 134 112 246 (13.5%)
Level of education
None 284 204 488 (26.7%)
Primary school 398 314 712 (39%)
Secondary school 290 151 441 (24.1%)
More than secondary school 112 71 183 (10%)
Body Mass Index (Kg/m2)
<18.5 42 66 108 (5.9%)
18.5e24.9 640 596 1236 (67.7%)
25e29.9 201 111 312 (17.1%)
>30 76 32 108 (5.9%)
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women: 8.4%) andCOPD was diagnosed in 113 (15.8%)
subjects aged 40 years and above. The number of subjects
with airflow limitation by fixed ratio increased as the
subjects’ age increased. For the subjects aged 45 years and
above, airflow limitation was found in 61 (9.6%) subjects
when we used the LLN criterion and in 91 (14.4%) subjects
when we used the fixed ratio criterion.
Skin prick test
484 participants (26.5%) had a positive skin-prick test
meaning a wheal at least 3 mm greater than the negative
control. House dust mites and grass pollen were the main
allergens found with respectively 10.7% (13.2% in Kigali
versus 7.6% in Huye) and 7.2% (5.8% in Kigali versus 9.1% in
Huye) sensitized participants. The other sensitizations were
as follow: cat dander 3.2%, dog dander 2.3%, cockroach
1.8% and Aspergillus 1.3%. (Table 6)
Sensitisation by site
Sensitization to House dust mites was mainly seen in Kigali
compared to Huye District (P < 0.001).Risk factors
The prevalence of COPD was higher among smokers than
non-smokers. By bivariate analysis male sex, old age and
smoking were risk factors for COPD. We did not find any
correlations between COPD and the level of education,
residence and other types of exposures (smoke from
wood and charcoal stoves, biomass, exposure at work) or
BMI.
Asthma was clearly associated with atopy. Living in
Kigali town was also a risk factor for having asthma
(p < 0.05). Wheezing was associated significantly to asthma
(OR :7.02; CI 3.12e9.68, P < 0.001). (Table.7) Female
gender and the low level of education is also associated
with asthma: we found more asthmatics in subjects who
had never been to school or had only a basic education in
basic schools.(Table 7)
By multiple logistic regression, smoking (OR: 3.9; CI:
2.12e5.71), higher age (above 45 years OR: 8.22, CI :
3.08e53.1) and male sex (OR: 2.97; CI: 1.96e4.22)
remained independent predictors for COPD. For asthma risk
factors were, atopy (OR: 4.01; CI: 2.86e5.13), female sex
(OR: 1.99; CI: 1.18e3.69), living in Kigali (OR: 3.62; CI:
2.12e5.78), and low level of education (OR: 1.71; CI:
1.23e3.31)
Table 2 Description of the population according to smoking history and other type of exposures.
Variables Kigali Huye N
Smoking history
Never smoked 612 622 1234 (67.7%)
Male 218 302 520 (59.2%)
Female 394 320 714 (75.5%)
Ex-smokers 163 123 286 (15.7%)
Male 102 72 174 (19.8%)
Female 61 51 112 (11.8%)
Current smokers 189 115 304 (16.7%)
Male 98 86 184 (20.9%)
Female 91 29 120 (12.6%)
Lifetime cigarettes smoked
<1 pack-year 126 91 217 (11.8%)
1e10 pack-years 124 109 233 (12.7%)
>10 pack-years 84 56 140 (7.6%)
Passive smoking
Yes 298 244 542 (29.7%)
No 714 568 1282 (70.2%)
Exposure at work
None 698 658 1356 (74.3%)
Dust 202 172 374 (20.5%)
Chemical fume 36 6.0 42 (2.3%)
Gas 44 8.0 52 (2.8%)
Do you cook?
Yes 418 680 1098 (60.1%)
No 388 338 726 (39.8%)
Exposure to biomass 50 48 98 (5.3%)
Exposure to charcoal 412 104 516 (28.2%)
Exposure to wood stove 210 276 486 (26.6%)
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In developing countries, chronic respiratory diseases
represent a challenge to public health because of their
frequency, severity, projected trends and economic
impact.7 The aim of this study was to determine the prev-
alence of asthma, atopy and COPD in Rwanda using ques-
tionnaires, spirometry and allergy skin-prick tests.
Spirometry in Rwanda is not done routinely in medical
practice due to lack of specialized technicians, doctors andTable 3 Frequency of respiratory symptoms of chronic airways
Variables Kigali
Wheezing 124
Cough 196
Breathlessness 61
Phlegm 70
Cough þ phlegm 44
Family history of CPD 59
Asthma diagnosed by Physician 76
COPD diagnosed by Physician 9.0
Self reported chronic bronchitis 79
History of tuberculosis 22
History of tuberculosis þ Wheezes 12
CPD: chronic pulmonary disease.equipments. Asthma was diagnosed in 8.9% of subjects and
was significantly associated with atopy.
Few studies on asthma have been conducted in Africa
and an increase in asthma prevalence has been noted by
other authors who also reported allergy as an important risk
factor for asthma.7,22,23 Westernization of lifestyle plays an
important role in the development of asthma and allergic
diseases.24 A study carried out by Sunyer J.et al.25 in
Tanzania, one of the neighbouring countries to Rwanda
reported a complexity in the association between asthmadiseases.
Huye N
104 228 (12.5%)
132 328 (17.9%)
77 138 (7.6%)
61 131 (7.2%)
52 96 (5.2%)
51 110 (6.0%)
45 121 (6.6%)
12 21 (1.2%)
75 154 (8.4%)
15 37 (2.0%)
12 24 (1.3%)
Table 4 Prevalence of atopy, asthma and COPD.
Total Age group Men Women P-value
Atopy 290 <45 137 153 NS
194 45 91 103 NS
Asthma 113 <45 54 59 NS
50 45 22 28 NS
COPD 22 <45 10 12 NS
60 45 50 10 <0.001
NS: not significant.
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reactivity to environmental allergens may not be related to
asthma. One of our study limitations is that we did not take
sera for specific IgE antibodies analysis.
Sensitisation to house dust mites is the most common
allergy detected in our study especially in Kigali. Previous
studies conducted in Europe showed that house dust mites
were uncommon in high altitudes,26,27 Kigali and Huye are
localized respectively at 1568 and 1768 m of altitude. Val-
divieso et al.28 reported recently the presence of mites at
an altitude of 4800 m in Ecuador. Earlier in 2006, the same
author reported the presence of frequent and abundant
mites and their allergens in dust samples at an altitude
between 2500 and 2800 m.29 Climatic differences in
particular differences in ambient humidity may explain the
situation. Other African studies also revealed house dust
mites as the most common allergens.30,31
We showed an association between the low level of
education with asthma. Even if we did not find a significant
association between asthma and various exposures at work,
we speculate that this can be partly explained by the fact
that subjects with low level of education are the same who
have low income and who live in poor condition, thus more
exposed to allergens and various irritants.
Living in Kigali was associated with asthma (OR: 2.21 CI
(2.32e4.54). Kigali is the capital of Rwanda, more urban-
ized and more polluted than Huye district which is mainly
rural. Outdoor air pollution has been studied as a risk factor
for asthma and high levels of traffic related emissions have
been correlated to increased prevalence of respiratory
allergies.32,33Table 5 Spirometry baseline information by gender.a
Characteristics Men (n Z 8
Mean age 38.1
Height 172.2  6.6
Weight 72.2  11
BMI 24.6  3.1
FEV1(L) 3.34  0.6
FEV1 (%) 88.3  11
FVC (L) 3.98  0.6
FVC% 94  13
FEV1/FVC (%) 82.6  6.6
PEFR Ls1 8.9  1.6
a Value are given as mean  standard deviation (SD).Among subjects aged 45 years and above, COPD was
diagnosed in 9.6% participants. Not all subjects with COPD
were smokers, about one third of subjects with COPD
were non-smokers. Although exposure to passive smoking,
biomass, smoke from wood and charcoal stoves did not
show a statistically significant effect, we believe that
they may be the possible causes of COPD in non-smokers.
An association between exposure to indoor air pollution
and the development of COPD has been reported
previously.34
The overall prevalence of COPD for all participants (1824
individuals) was 4.5% and association with tobacco smoking,
male sex and older age was observed. For subjects aged
45 years, the prevalence is fairly similar to results from
other studies from Europe, Asia or America.,35,36,37,38
Furthermore, our prevalence of COPD among smokers
(11.2% in current smokers and 8.6% in ex-smokers) is similar
to previous findings.35,39,40 The overall prevalence in our
study is low because of the low mean age in our study
sample with two thirds of subjects being below the age of
45 years. In Africa, there is very limited published data on
COPD, studies on selected populations showed highly vari-
able prevalence rates ranging from 5.3% to 47%.40
Considering both ex-smokers and current smokers in our
study, we have in total 32.3% of subjects who had a smoking
history. However, though this number seems to be high, few
were heavy smokers; moreover, during interviews we noted
a tendency of quitting smoking due to new regulatory
measures against tobacco consumption in Rwanda. Smoking
for women is still a taboo in the country, it is more toler-
ated for old women than younger ones.78) Women (n Z 946)
38.6
0 161.4  5.4
.8 60.2  8.3
23 4  3.2
0 2.42  0.44
.1 82.1  7.4
1 2.87  0.54
.2 89  11,8
84.4  5.1
8 6.2  1.48
Table 6 Frequency of sensitisation determined by skin-prick testing.
Allergen extract Site Positive skin reactivity N
(%)
P-value
Kigali Huye
Dermatophagoides
Pteronyssinus
136 (13.2%) 60 (7.6%) 196 (10.7%) P < 0.001
Grass pollen 60 (5.8%) 72 (9.1%) 132 (7.2%) NS
Cat dander 39 (3.8%) 21 (2.7%) 60 (3.2%) NS
Dog dander 13 (1.2%) 29 (3.7%) 42 (2.3%) NS
Cockroach 10 (1.0%) 22 (2.8%) 32 (1.9%) NS
Aspergillus 22 (2.2%) 1.0 (0.2%) 23 (1.3%) NS
NS: not significant.
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6.1% had a doctor diagnosis of the disease, confirming the
fact that COPD is under diagnosed.41 The absence of
spirometry in most hospitals in Rwanda is a major handicap
to the diagnosis of COPD and there is a frequent overlap of
asthma and COPD. The case definition for COPD is prob-
lematic in developing countries where the prevalence ofTable 7 Risk factors for Asthma and COPD.
Variables N Asthma
% OR: CI 95%
Overall 1824 8.9 e
Sex
Female 946 9.1 1
Male 878 8.7 0.22 (0.36e0.79)
Age
<45 years 1189 9.5 1
45 years 635 7.8 0.92 (0.65e2.21)
Smoking
Never 1234 9.4 1
Ex-smokers 286 7.3 0.70 (0.33e2.92)
Current smokers 304 8.6 0.92 (0.55e2.61)
Atopy
No 1340 3.8 1
Yes 484 23.1 5.24 (3.15e8.22)
Wheezing
No 1596 1.5 1
Yes 228 60.9 5.24 (3.15e8.22)
Residence
Huye 788 8.3 1
Kigali 1036 9.3 2.21 (1.32e4.54)
Level of education
None 488 12.2 2.71 (1.53e6.22)
Primary school 712 9.5 2.12 (1.32e4.26)
Secondary 441 5.2 1.35 (0.68e2.31)
More than secondary 183 6.5 1
Exposure to dust at work
No 1450 8.8 1
Yes 374 9.3 0.68 (0.39e2.14)
Exposure to wood stoves
No 1336 9.7 1
Yes 486 6.7 0.52 (0.41e1.89)
OR, Odds ratio (Adjusted for age and sex); CI, Confidence interval.lung infections including tuberculosis is still high and
a fraction of patients develop chronic irreversible airflow
obstruction as a result of these conditions or from both
smoking and sequelae of lung infection.42
More than 50% of participants reported exposure to
charcoal and wood stoves, but we did not find any associ-
ation with COPD. Woods and charcoal are used in all thep value COPD p value
% OR: CI 95%
4.5 e
2.3 1
p < 0.05 6.8 3.21 (2.44e6.32) p < 0.001
1.8 1
p Z 0.601 9.6 9.56 (3.12e60.9) p < 0.001
1.9 1
8.6 2.02 (1.27e4.92)
p Z 0.612 11.2 3.22 (1.53e4.31) p < 0.05
3.2 1
p < 0.05 7.2 0.24 (0.09e1.32) p Z 0.964
3.2 1
p < 0.05 7.2 0.24 (0.09e1.32) p Z 0.661
5.6 1
p < 0.05 3.6 0.72 (0.58e2.28) p Z 0.667
p Z 0.010 5.1 0.23 (0.09e0.95) p Z 0.923
2.9 0.26 (0.12e1.03)
5.5 0.51 (0.32e1.90)
6.2 1
4.3 1
p Z 0.672 5.2 0.92 (0.51e1.88) p Z 0.611
4.0 1
p Z 0.714 5.7 0.31 (0.22e1.48) p Z 0.701
1604 S. Musafiri et al.country for cooking, but the exposure is minor since many
Rwandans cook outdoor.
Conclusion
This is the first study which shows the prevalence of atopy,
asthma and COPD in Rwanda. Asthma and COPD were
respectively diagnosed in 8.9% and 4.5% of participants.
COPD was diagnosed in 9.6% of subjects aged 45 years and
was higher among current smokers (11.2%). The prevalence
of asthma was higher in urban compared to rural area and
a quarter of subjects were sensitized to various allergens.
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